You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 287 No. 2, January 9, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Research Yields Clues to Improving Cell Therapy for Parkinson Disease

M. J. Friedrich

JAMA. 2002;287:175-176.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

San Diego—After two airplanes sliced into New York City's World Trade Center towers on the morning of September 11, thousands of people navigated through smoke, fear, and confusion to emerge from the stricken buildings. Among the survivors was a man with Parkinson disease (PD), an electrician working on the 34th floor of one of the towers, who several years earlier had participated in a study in which fetal dopamine neurons were implanted in his brain.

Unimpeded by the slowed movements and shuffling steps that progressively immobilize people with PD, he descended 33 flights of stairs, ran five blocks when the buildings collapsed, and walked three miles to Penn Station to wait for a train to take him home.

"This man comes as close to a transplant cure for PD as any we've seen," said Curt Freed, MD, of the University of Colorado School of Medicine, Denver, . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.